Magic mushroom compound tested as new hope for fibromyalgia pain
NCT ID NCT06368492
Summary
This study is investigating whether low, non-hallucinogenic doses of psilocybin—the active compound in 'magic mushrooms'—can help reduce pain in people with fibromyalgia. It will involve 35 participants who will receive either a placebo or one of two low doses of psilocybin to see how it affects their pain perception. The goal is to see if this approach offers a new way to ease the chronic pain associated with this difficult-to-treat condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FIBROMYALGIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Leiden University Medical Center
RECRUITINGLeiden, South Holland, 2333, Netherlands
Contact Email: •••••@•••••
-
Maastricht University
RECRUITINGMaastricht, Limburg, 6226AK, Netherlands
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.